Correlation Between National Vision and Apogee Therapeutics,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both National Vision and Apogee Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining National Vision and Apogee Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between National Vision Holdings and Apogee Therapeutics, Common, you can compare the effects of market volatilities on National Vision and Apogee Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in National Vision with a short position of Apogee Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of National Vision and Apogee Therapeutics,.

Diversification Opportunities for National Vision and Apogee Therapeutics,

-0.37
  Correlation Coefficient

Very good diversification

The 3 months correlation between National and Apogee is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding National Vision Holdings and Apogee Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apogee Therapeutics, and National Vision is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on National Vision Holdings are associated (or correlated) with Apogee Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apogee Therapeutics, has no effect on the direction of National Vision i.e., National Vision and Apogee Therapeutics, go up and down completely randomly.

Pair Corralation between National Vision and Apogee Therapeutics,

Considering the 90-day investment horizon National Vision Holdings is expected to under-perform the Apogee Therapeutics,. But the stock apears to be less risky and, when comparing its historical volatility, National Vision Holdings is 1.34 times less risky than Apogee Therapeutics,. The stock trades about -0.04 of its potential returns per unit of risk. The Apogee Therapeutics, Common is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  4,716  in Apogee Therapeutics, Common on October 6, 2024 and sell it today you would earn a total of  61.00  from holding Apogee Therapeutics, Common or generate 1.29% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

National Vision Holdings  vs.  Apogee Therapeutics, Common

 Performance 
       Timeline  
National Vision Holdings 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in National Vision Holdings are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent basic indicators, National Vision may actually be approaching a critical reversion point that can send shares even higher in February 2025.
Apogee Therapeutics, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Apogee Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

National Vision and Apogee Therapeutics, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with National Vision and Apogee Therapeutics,

The main advantage of trading using opposite National Vision and Apogee Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if National Vision position performs unexpectedly, Apogee Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apogee Therapeutics, will offset losses from the drop in Apogee Therapeutics,'s long position.
The idea behind National Vision Holdings and Apogee Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance